Erasca, Inc. · NASDAQ:ERAS
Frazier Life Sciences Public Fund, L.P. reported a 5.30% stake in Erasca, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Frazier Life Sciences Public Fund, L.P. reported a 5.30% stake in Erasca, Inc., 15,038,753 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 5.30%
- Shares
- 15,038,753
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 17 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 5.30% | 15,038,753 |
| FHMLSP, L.P. | 5.30% | 15,038,753 |
| FHMLSP, L.L.C. | 5.30% | 15,038,753 |
| Frazier Life Sciences Public Overage Fund, L.P. | 0.80% | 2,405,634 |
| FHMLSP Overage, L.P. | 0.80% | 2,405,634 |
| FHMLSP Overage, L.L.C. | 0.80% | 2,405,634 |
| Frazier Life Sciences X, L.P. | 0.60% | 1,674,681 |
| FHMLS X, L.P. | 0.60% | 1,674,681 |
| FHMLS X, L.L.C. | 0.60% | 1,674,681 |
| Frazier Life Sciences XI, L.P. | 1.30% | 3,610,368 |
| FHMLS XI, L.P. | 1.30% | 3,610,368 |
| FHMLS XI, L.L.C. | 1.30% | 3,610,368 |
| James N. Topper | 0.60% | 1,674,681 |
| Patrick J. Heron | 0.60% | 1,674,681 |
| Albert Cha | 0% | 0 |
| James Brush | 0% | 0 |
| Daniel Estes | 0% | 0 |
Source
Related
- Erasca, Inc.
- Frazier Life Sciences Public Fund, L.P.
- Erasca, Inc. shareholders
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · May 15, 2025
- Schedule 13G/A · Jonathan E. Lim · Aug 14, 2026
- Schedule 13G/A · Paradigm Biocapital Advisors LP · May 15, 2026
- Schedule 13G · Rtw Investments, LP · May 15, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · May 15, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · May 15, 2026